Nushmia Khokhar, M.D.
Chief Medical Officer
Dr. Nushmia Khokhar is the Chief Medical Officer of Umoja Biopharma. She brings more than a decade of experience in oncology research and development to the role.
Prior to joining Umoja, Nushmia was the Senior Vice President, Head of Clinical Development at Autolus where she played a critical role in advancing the company’s autologous T-cell products and clinical programs. She also held numerous roles at Janssen Oncology including Associate Director of Oncology Research and Development and Director of Clinical Development/Oncology Research and Development. In these roles, Nushmia was instrumental in leading several successful clinical trials and directing the Phase 3 registration trial of Yondelis in soft tissue sarcomas. She later served as the Global Clinical Leader for the breakthrough therapy daratumumab (Darzalex) for hematologic cancers.
Nushmia received her medical training from the Aga Khan University in Pakistan before completing a post-doctoral fellowship at Memorial Sloan-Kettering Cancer Center with a focus on pharmacology and molecular therapeutics. She completed a residency in internal medicine at Washington Hospital Center in Washington, D.C. prior to completing a Hematology/Oncology Fellowship at the Northwestern University Feinberg School of Medicine.